Ultrasound-based Control of Micro-Bubbles for Exosome Delivery in Treating COVID-19 Lung Damage
Bruna Fonseca, Caio Fonseca, Michael Barros, Mark White, Vinay, Abhyankar, David A. Borkholder, Sasitharan Balasubramaniam

TL;DR
This paper proposes a novel ultrasound-controlled micro-bubble system loaded with exosomes to deliver targeted therapy for COVID-19 lung damage, demonstrating potential for immediate rescue and relapse treatment.
Contribution
It introduces a new method using ultrasound-activated micro-bubbles with exosomes for targeted lung therapy in COVID-19 patients, supported by simulation results.
Findings
Ultrasound signals with low frequencies can rupture micro-bubbles.
Simulations show ultrasound can penetrate tissue layers to reach alveoli.
Micro-bubbles can remain dormant until ultrasound activation.
Abstract
The recent COVID-19 pandemic has resulted in high fatality rates, especially for patients who suffer from underlying health issues. One of the more serious symptoms exhibited from patients suffering from an acute COVID-19 infection is breathing difficulties and shortness of breath, which is largely due to the excessive fluid (cellular leakage and cytokine storm) and mucoid debris that have filled lung alveoli, and reduced the surfactant tension resulting in heavy and stiff lungs. In this paper, we propose the use of micro-bubbles filled with exosomes that can be released upon exposure to ultrasound signals as possible rescue therapy in deteriorating COVID-19 patients. Recent studies have shown that exosomes can be used to repair and treat lung damage for patients who have suffered from viral infection. We have conducted simulations to show the efficacy of the ultrasound signals that…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
